文献速递骨质疏松与代谢性骨病创伤骨科

C反应蛋白可预测老年男性骨内膜扩张但不预测骨折:前瞻性STRAMBO研究

C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study.
PubMed 文献 · Osteoporos Int · 2022-12-26

在823名60-88岁老年男性中,基线高敏C反应蛋白(hsCRP)较高与全身体积骨密度(aBMD)及腰椎aBMD增加更快、桡骨远端和胫骨远端骨内膜扩张更快相关,胫骨远端总容积骨密度(vBMD)、皮质vBMD及失效载荷下降更明显,但hsCRP水平与8年骨折风险无关。

要点

  • 较高hsCRP与桡骨远端和胫骨远端骨内膜扩张更快相关,胫骨远端为0.123 mm²/年/SD(p<0.001)。
  • 较高hsCRP与胫骨远端总vBMD、皮质vBMD及失效载荷下降更明显相关,但与骨折风险无关。
  • hsCRP对老年男性骨量下降的影响有限。

核心结论

  • 较高hsCRP水平与桡骨远端和胫骨远端骨内膜扩张更快相关。
  • 较高hsCRP与胫骨远端总vBMD、皮质vBMD及失效载荷下降稍快相关,但与骨折风险无关。
  • 因此,较高hsCRP水平与老年男性皮质骨丢失更快相关,但与骨折风险无关。

研究设计与样本

  • 前瞻性STRAMBO研究在基线测量823名60-88岁男性的hsCRP,并在基线及第4年和第8年用双能X线吸收法评估面积骨密度(aBMD)、用高分辨率外周定量CT评估桡骨远端和胫骨远端骨微结构,收集8年骨折数据。

主要发现

  • 较高hsCRP浓度与全身和腰椎aBMD增加更快相关,与其他部位无关。
  • 较高hsCRP水平与桡骨远端皮质面积减少更快和骨小梁面积增加更快相关(0.048 mm²/年/SD,p<0.05),胫骨远端相应变化为0.123 mm²/年/SD(p<0.001)。
  • 在胫骨远端,较高hsCRP水平与总vBMD、皮质vBMD及失效载荷下降更明显相关。
  • hsCRP水平与骨折风险无关,即使考虑死亡竞争风险后仍无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In older men, higher high-sensitivity C-reactive protein (hsCRP) concentrations were associated with faster prospectively assessed endocortical expansion (distal radius, distal tibia) and slightly higher cortical bone loss at distal tibia, but not with the fracture risk. High hsCRP level has a limited impact on bone decline in older men. PURPOSE: Data on the link of the high-sensitivity C-reactive protein (hsCRP) with bone loss and fracture risk are discordant. We studied the association of the hsCRP with the prospectively assessed decrease in areal bone mineral density (aBMD), bone microarchitecture decline, and fracture risk in older men. METHODS: At baseline, hsCRP was measured in 823 men aged 60-88. Areal BMD and bone microarchitecture (distal radius, distal tibia) were assessed by dual-energy X-ray absorptiometry and high-resolution peripheral QCT, respectively, at baseline and after 4 and 8 years. Data on incident fractures were collected for 8 years. RESULTS: Higher hsCRP concentration was associated with faster increase in aBMD at the whole body and lumbar spine, but not other sites. Higher hsCRP levels were associated with faster decrease in cortical area and more rapid increase in trabecular area at the distal radius (0.048 mm2/year/SD, p < 0.05) and distal tibia (0.123 mm2/year/SD, p < 0.001). At the distal tibia, high hsCRP level was associated with greater decrease in total and cortical volumetric BMD (vBMD) and in failure load. The hsCRP levels were not associated with the fracture risk, even after accounting for competing risk of death. CONCLUSION: Higher hsCRP levels were associated with greater endocortical expansion at the distal radius and tibia. Higher hsCRP was associated with slightly faster decrease in total and cortical vBMD and failure load at distal tibia, but not with the fracture risk. Thus, high hsCRP levels are associated with faster cortical bone loss, but not with fracture risk in older men.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Girard D, Wagner PP, Whittier DE, et al. C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study. Osteoporos Int. 2022. PMID: 36567328. doi:10.1007/s00198-022-06652-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。